News

Cardinal Health Fuels Prescription Access with $5M Expansion

Cardinal Health Fuels Prescription Access with $5M Expansion

Enhancing Access to Medications with Equity Rx

Cardinal Health (NYSE: CAH) has taken a significant step forward in increasing access to prescription medications through its initiative, Equity Rx. With a total investment reaching $5 million, this expansion aims to support individuals who struggle to afford their medications. Initially launched in 2023, Equity Rx is a collaborative effort involving the Cardinal Health Foundation, the Charitable Healthcare Network (CHN), and St. Vincent de Paul Charitable Pharmacy.

Key Features of the Grant Funding

This latest round of funding will facilitate several crucial developments:

Statewide Expansion of Equity Rx Activities

The funds will allow the equity program to extend its reach from its origins in southwest Ohio into the northeast and southeast regions of the state, as well as into three additional states by teaming up with the National Association of Free and Charitable Clinics (NAFC).

Establishment of a Statewide Prescription Drug Repository

Moreover, the program will see the creation of Ohio's first statewide prescription drug repository. This facility will serve as a distribution center where donated medications can be sorted, catalogued, and prepared for free distribution through the CHN network of organizations.

Addressing the Medication Access Gap

Statistics show that a significant portion of the adult population in the U.S. engages in prescription drug use daily, yet a staggering 29% report they cannot fill their prescriptions due to high costs. This is particularly alarming for those facing chronic health conditions like diabetes or asthma, as they often require consistent access to their medications to manage their health effectively.

The Mission Behind Equity Rx

Jessie Cannon, President of the Cardinal Health Foundation, stated, "Equity Rx ensures patients in need can get their medications when they need them, while also providing access to pharmacists who can counsel them on health issues, medication adherence, and more." This initiative is a vital resource for many who may otherwise go without necessary treatment.

Progress and Success Stories

During its initial phase, the program successfully established a fund to enhance medication access at free clinics in southwest Ohio. The partnership with St. Vincent de Paul Charitable Pharmacy allowed for the direct delivery of medications to patients during primary care visits, significantly benefiting those in need. With support from both the Foundation and NAFC, Equity Rx has established programs in numerous clinics across several states, greatly extending its reach and impact.

Future of Medication Access

"Everyone should be able to access the medications and care they need," stated Jason Koma, executive director of the Charitable Healthcare Network. Equity Rx is actively working to dismantle barriers in medication access and aims to replicate its model on a national scale in the future, thus revolutionizing how patients access their medications.

Establishing Ohio's First Drug Repository

Rusty Curington, PharmD, vice president of pharmacy at St. Vincent de Paul Charitable Pharmacy, shared insights on the new repository, stating, "Millions of dollars' worth of safe, unexpired medications are wasted each year." By creating a streamlined procedure for the donation and redistribution of medications, the repository aims to safely recycle surplus drugs and enhance care accessibility across the state.

Operational Timeline and Goals

Located at St. Vincent de Paul Charitable Pharmacy and partnered with the Ohio State Board of Pharmacy, the new repository is set to commence operations after two years of planning, with the expectation to be fully functional in 2027. A portion of the funds granted will be allocated toward start-up operations and innovative technologies needed for the repository.

About Cardinal Health

Cardinal Health is a prominent distributor of pharmaceuticals and medical products, focusing on providing essential services within the healthcare landscape. Their commitment to customer-centric solutions drives innovation that enhances quality of life for individuals and communities every day.

Frequently Asked Questions

What is Equity Rx?

Equity Rx is an initiative by Cardinal Health that aims to improve access to prescription medications for those in need, particularly focusing on underserved communities.

How much funding has been invested in Equity Rx?

The Cardinal Health Foundation has invested a total of $5 million into the Equity Rx program to support its expansion and initiatives.

What are the expected outcomes of the statewide drug repository?

The repository aims to streamline the donation of unused medications, preventing waste while increasing access to necessary medications for healthcare organizations serving the community.

How does Equity Rx benefit patients with chronic conditions?

This program particularly assists patients with chronic conditions by ensuring they can access their medications affordably, improving their health management and overall quality of life.

What is the timeline for the drug repository to become operational?

The Ohio drug repository aims to be fully operational in 2027, following a two-year planning and development period.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 32

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 31

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 26

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 32

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 36

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 23

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading

Top 5 Most Recently Viewed Articles

ZTO Express Highlights Convertible Note Repurchase Opportunity

Updated Category News Views 114

Understanding ZTO Express's Convertible Note Repurchase Right ZTO Express (Cayman) Inc. (NYSE: ZTO), a key player in the express delivery sector, recently informed its bondholders about their rights regarding the 1.50% Convertible Senior Notes due 2027. The company offers an opportunity for holders to request the repurchase of their notes in cash, giving them a strategic...

Continue Reading
EVERSANA's AI Expands: Revolutionizing Life Sciences

Updated Category News Views 11

A Bold Leap in AI Commercialization Look, fresh off the press, EVERSANA is making some waves. They’ve expanded their AI-powered commercialization platform, aiming to overhaul life sciences operations. Sounds like a mouthful, right? Well, let's break it down. This expansion isn't just a facelift; it's part of a bigger vision to create a nimble, AI-native ecosystem for...

Continue Reading
Wabtec Corporation's Q3 Performance: Growth and Opportunities

Updated Category News Views 93

Wabtec Corporation Delivers Strong Third Quarter Results Wabtec Corporation (NYSE: WAB) has announced a solid performance for the third quarter, reporting a notable 4.5% increase in sales, reaching $2.7 billion compared to the same period last year. This growth can be attributed to the robust performance in its freight and transit sectors. The company also shared that the...

Continue Reading
Exploring Job Creation and Economic Growth by Argosy Investments

Updated Category News Views 119

Argosy Real Estate Partners and Economic Development Argosy Real Estate Partners, a dedicated private real estate investment manager, has recently shared compelling insights from its Opportunity Zone Economic Impact Analysis. The firm emphasizes its commitment to fostering positive growth in communities by investing in Qualified Opportunity Zones. This analysis showcases...

Continue Reading
Join Vow ASA for the Exciting Q3 2024 Results Presentation

Updated Category News Views 101

Vow ASA Invites You to Its Third Quarter 2024 Presentation Vow ASA (OSE: VOW) is gearing up to unveil its much-anticipated report for the third quarter of 2024. Mark your calendars for this significant event on a Tuesday morning, when the company's financial performance and insights will be shared with the world. Presentation Details The results will be available for...

Continue Reading